Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Zorzato, F.
Right arrow Articles by Treves, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zorzato, F.
Right arrow Articles by Treves, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2003, Vol. 12, No. 4 379-388
© 2003 Oxford University Press

Clinical and functional effects of a deletion in a COOH-terminal lumenal loop of the skeletal muscle ryanodine receptor

Francesco Zorzato1,2, Naohiro Yamaguchi3, Le Xu3, Gerhard Meissner3, Clemens R. Müller4, Pierre Pouliquin2, Francesco Muntoni5, Caroline Sewry5, Thierry Girard1 and Susan Treves1,*

1Departments für Anaesthesie und Forschung, Kantonsspital Basel, 4031 Basel, Switzerland, 2Dipartimento di Medicina Sperimentale e Diagnostica, Università di Ferrara, 44100 Ferrara, Italy, 3Departments of Biochemistry and Biophysics and Molecular and Cellular Physiology, University of North Carolina, Chapel Hill, NC 27599-7260, USA, 4Institut für Humangenetik, Biozentrum der Universität Würzburg, 97074 Würzburg, Germany and 5The Dubowitz Neuromuscular Centre, Imperial College School of Medicine, London W12 0NN, UK

Received October 25, 2002; Accepted December 3, 2002

We have identified a patient affected by a relatively severe form of central core disease (CCD), carrying a heterozygous deletion (amino acids 4863–4869) in the pore-forming region of the sarcoplasmic reticulum calcium release channel. The functional effect of this deletion was investigated (i) in lymphoblastoid cells from the affected patient and her mother, who was also found to harbour the mutation and (ii) in HEK293 cells expressing recombinant mutant channels. Lymphoblastoid cells carrying the RYR1 deletion exhibit an ‘unprompted’ calcium release from intracellular stores, resulting in significantly smaller thapsigargin-sensitive intracellular Ca2+ stores, compared with lymphoblastoid cells from control individuals. Blocking the RYR1 with dantrolene restored the intracellular calcium stores to levels similar to those found in control cells. Single channel and [3H]ryanodine binding measurements of heterologously expressed mutant channels revealed a reduced ion conductance and loss of ryanodine binding and regulation by Ca2+. Heterologous expression of recombinant RYR1 peptides and analysis of their membrane topology demonstrate that the deleted amino acids are localized in the lumenal loop connecting membrane-spanning segments M8 and M10. We provide evidence that a deletion in the lumenal loop of RYR1alters channel function and causes CCD.

* To whom correspondence should be addressed at: ZLF Basel Kantonsspital, Lab 408, Hebelstrasse 20, 4031 Basel, Switzerland. Tel: +41 612652373; Fax: +41 612653702; Email: susan.treves{at}unibas.ch


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BrainHome page
H. Zhou, H. Jungbluth, C. A. Sewry, L. Feng, E. Bertini, K. Bushby, V. Straub, H. Roper, M. R. Rose, M. Brockington, et al.
Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies
Brain, August 1, 2007; 130(8): 2024 - 2036.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
H. Zhou, N. Yamaguchi, L. Xu, Y. Wang, C. Sewry, H. Jungbluth, F. Zorzato, E. Bertini, F. Muntoni, G. Meissner, et al.
Characterization of recessive RYR1 mutations in core myopathies
Hum. Mol. Genet., September 15, 2006; 15(18): 2791 - 2803.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
S. Wu, M C. A. Ibarra, M. C. V. Malicdan, K. Murayama, Y. Ichihara, H. Kikuchi, I. Nonaka, S. Noguchi, Y. K. Hayashi, and I. Nishino
Central core disease is due to RYR1 mutations in more than 90% of patients
Brain, June 1, 2006; 129(6): 1470 - 1480.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Kobayashi, M. L. Bannister, J. P. Gangopadhyay, T. Hamada, J. Parness, and N. Ikemoto
Dantrolene Stabilizes Domain Interactions within the Ryanodine Receptor
J. Biol. Chem., February 25, 2005; 280(8): 6580 - 6587.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Ducreux, F. Zorzato, C. Muller, C. Sewry, F. Muntoni, R. Quinlivan, G. Restagno, T. Girard, and S. Treves
Effect of Ryanodine Receptor Mutations on Interleukin-6 Release and Intracellular Calcium Homeostasis in Human Myotubes from Malignant Hyperthermia-susceptible Individuals and Patients Affected by Central Core Disease
J. Biol. Chem., October 15, 2004; 279(42): 43838 - 43846.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Bagattin, C. Veronese, B. Bauce, W. Wuyts, L. Settimo, A. Nava, A. Rampazzo, and G. A. Danieli
Denaturing HPLC-Based Approach for Detecting RYR2 Mutations Involved in Malignant Arrhythmias
Clin. Chem., July 1, 2004; 50(7): 1148 - 1155.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
F. Muntoni and C. A. Sewry
Central core disease: new findings in an old disease
Brain, November 1, 2003; 126(11): 2339 - 2340.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.